Blenoxane (bleomycin) is a small molecule pharmaceutical. Bleomycin was first approved as Blenoxane on 1982-01-01. It is used to treat choriocarcinoma, hodgkin disease, melanoma, non-hodgkin lymphoma, and sarcoma amongst others in the USA.
|Indication||choriocarcinoma, hodgkin disease, melanoma, non-hodgkin lymphoma, sarcoma, squamous cell carcinoma, teratocarcinoma, testicular neoplasms|
|Drug Class||Antibiotics (Streptomyces strains)|